Sodium selenate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSodium selenate
Drug Alias NameSe-015Ve-015VEL-015
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein phosphatase 2A stimulants
TargetsProtein phosphatase 2A
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVelacor Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVelacor Therapeutics
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeA12CE01
Related LinksN/A